Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Treilleux

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Bulletin Du Cancer|December 27, 2021
Diagnostic histologique et moléculaire des cancers de l'ovaire - recommandations pour la pratique clinique Saint-Paul 2021: Histological and molecular diagnosis of ovarianCatherine Genestie, Laurence Gladieff, Marie-Aude Le Frère-Belda, et al.
International Journal of Environmental Research and Public Health|May 14, 2022
Frequency of Asbestos Exposure and Histological Subtype of Ovarian CarcinomaPauline Vidican, Olivia Perol, Joëlle Fevotte, et al.
Journal of Cell Science|June 22, 2013
TIF1γ requires sumoylation to exert its repressive activity on TGFβ signalingLaurent Fattet, Anne-Sophie Ay, Benjamin Bonneau, et al.
The American Journal of Surgical Pathology|August 10, 2002
Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular componentMyriam Decaussin, Marie Hélène Bernard, Patrice Adeleine, et al.
Developmental Biology|May 30, 2008
Maternal Tgif is required for vascularization of the embryonic placentaLaurent Bartholin, Tiffany A Melhuish, Shannon E Powers, et al.
Cancer Management and Research|December 29, 2010
New developments in treatment of ovarian carcinoma: focus on trabectedinPhilippe A Cassier, Aude Duret, Olivier Trédan, et al.
Bulletin Du Cancer|January 20, 2012
First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancerJulien Peron, Olivier Tredan, Isabelle Ray-Coquard, et al.
Journal of Molecular Endocrinology|November 6, 2008
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancerSandra E Ghayad, Julie A Vendrell, Ivan Bieche, et al.
Oncotarget|June 22, 2018
CD73 expression and clinical significance in human metastatic melanomaInês Monteiro, Selena Vigano, Mohamed Faouzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2008
Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancerJulien Fitamant, Céline Guenebeaud, Marie-May Coissieux, et al.
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Bulletin Du Cancer|December 27, 2021
Diagnostic histologique et moléculaire des cancers de l'ovaire - recommandations pour la pratique clinique Saint-Paul 2021: Histological and molecular diagnosis of ovarianCatherine Genestie, Laurence Gladieff, Marie-Aude Le Frère-Belda, et al.
International Journal of Environmental Research and Public Health|May 14, 2022
Frequency of Asbestos Exposure and Histological Subtype of Ovarian CarcinomaPauline Vidican, Olivia Perol, Joëlle Fevotte, et al.
Journal of Cell Science|June 22, 2013
TIF1γ requires sumoylation to exert its repressive activity on TGFβ signalingLaurent Fattet, Anne-Sophie Ay, Benjamin Bonneau, et al.
The American Journal of Surgical Pathology|August 10, 2002
Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular componentMyriam Decaussin, Marie Hélène Bernard, Patrice Adeleine, et al.
Developmental Biology|May 30, 2008
Maternal Tgif is required for vascularization of the embryonic placentaLaurent Bartholin, Tiffany A Melhuish, Shannon E Powers, et al.
Cancer Management and Research|December 29, 2010
New developments in treatment of ovarian carcinoma: focus on trabectedinPhilippe A Cassier, Aude Duret, Olivier Trédan, et al.
Bulletin Du Cancer|January 20, 2012
First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancerJulien Peron, Olivier Tredan, Isabelle Ray-Coquard, et al.
Journal of Molecular Endocrinology|November 6, 2008
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancerSandra E Ghayad, Julie A Vendrell, Ivan Bieche, et al.
Oncotarget|June 22, 2018
CD73 expression and clinical significance in human metastatic melanomaInês Monteiro, Selena Vigano, Mohamed Faouzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2008
Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancerJulien Fitamant, Céline Guenebeaud, Marie-May Coissieux, et al.
Pageof 19